Acurx Pharmaceuticals Inc (ACXP)
2.55
-0.24
(-8.60%)
USD |
NASDAQ |
May 22, 16:00
2.55
0.00 (0.00%)
After-Hours: 20:00
Acurx Pharmaceuticals Cash from Operations (TTM): -10.93M for March 31, 2024
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
March 31, 2024 | -10.93M |
December 31, 2023 | -9.801M |
September 30, 2023 | -7.099M |
June 30, 2023 | -7.185M |
March 31, 2023 | -7.599M |
December 31, 2022 | -7.542M |
September 30, 2022 | -7.547M |
Date | Value |
---|---|
June 30, 2022 | -8.003M |
March 31, 2022 | -6.343M |
December 31, 2021 | -5.014M |
September 30, 2021 | -4.473M |
June 30, 2021 | -2.596M |
March 31, 2021 | -2.999M |
December 31, 2020 | -3.352M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-10.93M
Minimum
Mar 2024
-2.596M
Maximum
Jun 2021
-6.463M
Average
-7.142M
Median
Cash from Operations (TTM) Benchmarks
Seelos Therapeutics Inc | -18.21M |
Tonix Pharmaceuticals Holding Corp | -86.67M |
PetVivo Holdings Inc | -7.190M |
NovaBay Pharmaceuticals Inc | -4.516M |
Palatin Technologies Inc | -33.74M |